LintonPharm Announces Authorization From China Health Authority to Proceed With a Global Phase 3 Trial Evaluating Catumaxomab in Advanced Gastric Cancer
GUANGZHOU, China--(BUSINESS WIRE)--LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development…